References

Cunha et al. “Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.” Leprosy Reviews. Vol 75, Issue 4. Dec 2004. p. 357-66.

Gillis, Tom. Chief National Hansen’s Disease Programs Lab Research. Personal Interview. 22 May 2006.
Gormus et al. “Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.” Leprosy Reviews. Vol 73, Issue 3. Sep 2002. p. 254-61.
“Hansen’s Disease (Leprosy).” Division of Bacterial and Mycotic Diseases. Centers for Disease Control and Prevention. 12 Oct 2005. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/hansens_t.htm
“Hansen’s Disease Research.” National Hansen’s Disease Programs. Bureau of Primary Health Care. April 2006. http://www.bphc.hrsa.gov/nhdp/
Kartikeyan et al. “Anti-leprosy vaccines: current status and future prospects.” Journal of Postgraduate Medicine. Vol 37, Issue 4. 1991. p.198-204.
“Leprosy Research Support.” Colorado State University. 13 Jan 2005. http://www.cvmbs.colostate.edu/mip/leprosy/globalleprosy3.html
Strydjswka, Barbara. Clinician at the National Hansen’s Disease Programs. Personal Interview. 22 May 2006.
“The Continuing Challenges of Leprosy.” Scollard, Gillis, Truman, et al. Clinical Microbiology Reviews. April 2006, p.338-381, Vol. 19, No.2. http://cmr.asm.org/cgi/content/full/19/2/338
“Treatment Timeline.” Global Project on the History of Leprosy. International Leprosy Association. http://www.leprosyhistory.org/cgi-bin/treatmentyearrange.pl
Zopdey et al. “Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.” Public Health. Vol 119, Issue 3. March 2005. p. 209-216.

A Vaccine for Leprosy

References